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In the neurodevelopment of adolescent anorexia nervosa (AN), dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis
is proposed to be a central component. Furthermore, a therapeutic milieu focusing on aﬀect regulation can contribute much
to treatment, given the emotional processing diﬃculties associated with this disorder. Studies of HPA axis function following
such specialist treatments for adolescent AN, however, are rare. This study describes the diurnal pattern of HPA axis activation,
including the cortisol awakening response (CAR), in a 16-year-old female diagnosed with AN both during illness and at clinical
recovery following milieu therapy with a focus on aﬀect regulation. Specialised single-case study statistics were used to assess
whether the patient’s data were significantly diﬀerent from the healthy “norm” at illness and recovery. During illness, her measure
of aﬀective problems was outside of the normal range and cortisol and DHEA secretory profiles were significantly elevated across
the diurnal period. However, at recovery both her aﬀective state and HPA axis function became comparable to healthy controls.
This case study suggests that salivary markers of HPA axis function can be feasibly incorporated into the clinical regime within a
specialist adolescent AN residential service and could be used by clinicians to monitor prognosis and interventions.
1. Introduction
The neuropathophysiology of anorexia nervosa (AN)
remains complex, enigmatic, and controversial, and the
disorder is reported to aﬀect 0.5% of Western young women
[1]. Experienced clinicians recognise that the treatment
of severe, life threatening AN necessitates a multifaceted
approach, which best takes place within a specialised eating
disorder inpatient unit that can appropriately meet these
patients’ complex psychosocial and biological needs [2].
For more than 50 years the World Health Organisation
has recognised that “the creation of the atmosphere of a
therapeutic (milieu) is in itself, one of the most important
types of treatment which the hospital can provide” [3].
Milieu therapy, by definition, oﬀers the safety, structure,
support, validation, and involvement of living in a ther-
apeutic community [4]. Such a therapeutic environment
may hold especial promise for young patients with AN,
who are often observed to have great diﬃculty in regulating
and expressing their emotional states. This has led to the
suggestion that AN, especially in young girls is “an illness
of communication between the world inside themselves and
the world outside—an illness of emotional communication”
[5]. Research consistently presents findings of significantly
greater diﬃculties in emotional recognition, description, and
regulation in females with AN, especially adolescents [6–8].
Of particular importance is that female adolescents with
AN have been shown to have a discrepancy between neuroen-
docrine stress responses, in terms of the hormone cortisol,
and self-reported emotional arousal to psychosocial stress [9].
This suggests that cortisol could be a useful biomarker for
adolescent AN. Indeed, the hypothalamic-pituitary-adrenal
(HPA) axis has been proposed as a central component
of dysregulation in adolescent AN [10], as it provides
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an insight into “upstream” influences regarding stress and
the eﬀects on health and disease. It has been suggested that
an accurate understanding of HPA axis function at diﬀerent
stages of AN would enable more accurate and objective
monitoring of therapeutic progress, as well as vulnerability
[11].
Both cortisol and dehydroepiandrosterone (DHEA) are
important physiological mediators of the HPA axis, and are
measureable in saliva. Salivary measures of adrenal steroids
are well-established in psychoneuroendocrine research,
namely because the collection of samples is non-invasive,
thus multiple samples can be performed in the naturalistic
environment without the need for medical personnel [12,
13]. Cortisol and DHEA are valid candidates for clinically
relevant research because of their distinct rhythmicity; both
exhibit a marked circadian rhythm, with a diurnal decline
from a morning peak to an evening nadir [14, 15]. Therefore
deviations in the “norm” of these rhythms may provide
vital insights for understanding diﬀerent psychopathologies
[16, 17]. Awakening is a critical part of the diurnal cycle and
cortisol concentrations change rapidly during the immediate
post-awakening period, with up to 100% increase [18]. This
phenomenon is known as the cortisol awakening response
(CAR). The CAR is recognised as a distinct component
within the diurnal cortisol rhythm [12], and accordingly
should be analysed separately compared to the rest of the
daytime profile [19]. Dysregulation in the CAR has been
linked with chronic stress, major depressive disorder, and
a range of health conditions in adults [12, 20] as well as
children and adolescents [21–23].
However, despite the fact that the measurement of sali-
vary HPA axis hormones has been widely used in paediatric
research for more than 20 years [24], the employment of
such biomarkers in the field of AN, and adolescent AN in
particular, is somewhat lacking. The CAR, but not the rest
of the diurnal cycle, has recently been examined in a cross-
sectional study of adult female outpatients [25], and short
day-profiles only have been examined in female adolescents
[26]. It remains unknown whether the hypersecretion in AN
patients reported by both of these studies is accompanied by
normalisation on recovery. Studies of cortisol and DHEA in
AN include single, timed blood or saliva samples which only
provide snapshots of HPA axis activity (e.g., [27]). A study
examining HPA axis function synchronised to individual
awakening (to include the CAR) during illness in adolescent
AN and at clinical recovery, taking into account a measure of
aﬀect, is warranted.
We used a case study longitudinal approach to examine
the diurnal pattern of cortisol andDHEA secretion in a single
female adolescent both during illness and one year following
discharge from treatment (when she was clinically recovered
and back in community life). We set out to use the best-
recommended methodology for profiling salivary indicators
of HPA axis function: multiple samples over the day (separate
analysis of the awakening and daytime periods), strict
reference to time of awakening, two consecutive sampling
weekdays to check for consistency, and careful checks on
participant adherence to protocol. Furthermore, the present
study adds the complexity of specialised case study statistical
analyses to provide additional scrutiny in examining out-
comes. Overall, we aimed to examine the eﬀect of milieu
therapy focused on aﬀect regulation within a specialised
inpatient service for adolescent AN. Our hypothesis was that
at baseline, the patient’s diurnal rhythms of cortisol and
DHEA would be dysregulated and these indicators of HPA
axis would normalise when she was recovered.
2. Case Presentation
2.1. Patient Symptoms and Diagnosis. The case concerns
a 16-year-old female (referred to as Bella). On admission
to the inpatient treatment service Bella was assessed by
the consultant psychiatrist. She met DSM-IV diagnostic
criteria for AN (restricting type). She exhibited no comorbid
depressive or obsessive compulsive disorders and was not
taking any prescribed medication. When she participated
in the present study, her weight was 52.2 kg with a BMI
of 17.0 kg/m2. Bella was undergoing a medium to long
stay programme at the service, the duration of which is
usually between four to nine months. It has been suggested
that undertaking a saliva sampling protocol too close to
admission may not be favourable because the participant
may not have yet adjusted to their new environment, and
the stress of the hospital environment may aﬀect cortisol
levels [27], which is why Bella did not take part in the
study immediately at admission. She was followed up for
this research one year after being discharged from inpatient
treatment.
2.2. Treatment. The inpatient treatment service oﬀers a
“therapeutic milieu” which includes highly skilled nursing
care and tailored therapeutic approaches for each young
person. The centre’s philosophy was one that understood AN
to be the expression of major diﬃculties in self-regulation
with consequent eﬀects on emotional communication and
on physical health.
Bella followed a comprehensive routine and treatment
programme, which, in addition to milieu therapy, included
weekly individual psychotherapy, family therapy, and group
therapy. Problems identifying emotions in oneself and others
and handling relationships were targeted within individual,
group and family contexts. This supports research which
suggests that exploring the function of emotions and prac-
tising emotion recognition might be useful treatment targets
for AN [28]. Normalising eating behaviour and regaining
a healthy weight was an integral part of Bella’s treatment
programme. Bella’s plan set her rate of weight gain to roughly
between 0.5 kg and 1 kg per week, and to steady her weight
increase, her individual meal plans were adjusted according
to her treatment progress.
2.3. Participation in the Present Research. The treatment
centre participated in an established active research pro-
gramme, dedicated to investigating aspects of early onset
eating disorders with a particular focus on neuroscience and
aﬀect regulation. The present study was part of that research
programme, and Bella had volunteered to be a participant.
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Ethical approval for the study was obtained from both
the University of Westminster and Barnet and Haringey
Local Research Ethics Committees. The protocol involved the
following assessments, described below. The questionnaire
was chosen to assess Bella’s eating pathology pre- and post-
participation. After informed written consent was provided
by both Bella and her parents, the following assessments were
completed.
2.3.1. Eating Disorders Inventory-3 (EDI-3) [29]. The EDI-
3 contains 91 items which form various eating disorder
risk scales and psychological scales that are rated using a
six-point scoring format; the higher the scores for each
scale, the more symptomatic the individual. The diﬀerent
scales regarding disordered behaviours and psychological
traits can be collapsed to form two overall composite scores,
named eating disorder risk and the general psychological
maladjustment, the latter of which includes a measure of
aﬀective problems.
2.3.2. Salivary Cortisol and DHEA. Bella was provided with a
pack containing saliva samplingmaterials. She was instructed
to collect saliva samples at awakening, 15, 30, and 45 minutes
and 6 and 12 hours post-awakening on two consecutive
weekdays. Saliva was collected by passive drool through a
straw into the appropriately labelled small, plastic Eppendorf
tube. For at least 30 minutes prior to the collection of each
sample, she had to adhere by guidelines of nil by mouth
other than water and the avoidance of vigorous exercise and
brushing teeth. Other than these requests for compliance,
Bella was free to follow her normal daily routine. After
collection, Bella’s samples were frozen (−20◦C). On the last
day of Bella’s participation, the researcher used insulated
packs to transfer samples to the laboratory where they
were stored at −20◦C until assay. On each study day, Bella
recorded her awakening time, method of waking up (whether
naturally or by alarm clock) and the exact times of collection
of saliva samples. To maximise adherence to protocol, the
timing of all Bella’s samples was supervised by nursing staﬀ.
In the laboratory, Bella’s saliva samples were thawed
and centrifuged at 1500 xg (3000 rpm) for 15 minutes. Her
cortisol concentration were determined by the Expanded
Range High Sensitivity Enzyme Linked Immuno-Sorbent
Assay developed by Salimetrics LLC (USA). Similarly, the
Salimetrics Salivary DHEA Enzyme. For full details of the
assay procedure, see Oskis et al. [15].
2.4. Statistical Approach to the Case Report. Researchers now
have the opportunity to utilise statistical techniques that
allow single case studies to be amenable to the same statistical
research questions as larger-N research studies. These have
been especially useful within neuropsychology, where such
research findings translate to the clinical setting and facilitate
the development a case’s profile of cognitive strengths and
weakness [30]. However, these techniques are uncommon
within neuroendocrinology where the use of single case
studies is rare. Nevertheless, since our endeavour was the
same, namely to see whether our case study was significantly
diﬀerent on assessments compared to a matched control
sample, we chose to use the approach developed by Crawford
and Howell [30]. This method is eﬀectively a modified
independent samples t-test in which the individual is treated
as a sample of n = 1. The test is robust in that it controls the
Type I error rate regardless of the size of the control sample.
More recently, Crawford et al. [31] have further developed
this method so that as well as testing for a statistically
significant diﬀerence, an eﬀect size index for the diﬀerence
between the case and controls can also be obtained. This
index of eﬀect size, termed zCC, is analogous to Cohen’s d
and is an estimate of the average diﬀerence, measured in
standard deviation units, between a case’s score and the score
of a randomly chosen member of the control population.
The computer programme Singlims-ES implements these
methods and was used to analysis of Bella’s assessments
compared to a control group.
2.5. Outcome. Bella’s data were examined against a backdrop
of comparator participant data derived from a parallel, larger
study investigating HPA axis activity in healthy females [15].
This sample contained 15 post-menarche female adolescents
who were age matched (mean (±SD) age 16.67 (±0.49)
years), with normal BMI (21.39 kg/m2 ± 3.18).
Using Crawford and Howell’s [30] approach, Bella’s
mean cortisol and DHEA variables for the two samplings
day were analysed against the corresponding values from the
healthy control group to ascertain whether her values were
significantly diﬀerent. Composites were computed to repre-
sent the total concentrations and dynamic of each hormone,
in line with conventions in neuroendocrine research see
[32].
2.5.1. Baseline. Both Table 1 and Figure 1 illustrate Bella’s
cortisol profile at baseline when she was ill with AN, and one
year after being discharged from the inpatient service when
she was recovered. At baseline, Bella’s overall levels of cortisol
after awakening were significantly higher than those of the
control group. However, the dynamic of Bella’s CAR mean
increase did not diﬀer significantly to that of the controls.
For cortisol over the rest of the day, once again Bella’s
overall levels of cortisol from 6 to 12 hours post-awakening
were significantly greater but there was no diﬀerence in the
decline over this daytime period compared to the control
group.
Unlike cortisol, DHEA is not characterised by a marked
awakening response [14, 15]. Given this, only the sam-
ples taken at awakening, 30 minutes, and 12 hours post-
awakening were analysed for DHEA. Bella’s concentrations
in the 30 minute post-awakening period and in the evening
were significantly higher than the healthy control group
(see Table 1 and Figure 2). As can also be seen in Table 1,
Bella’s eating pathology assessments at baseline confirmed
her diagnosis and her EDI-3 scores for eating disorder
risk, particularly the body dissatisfaction scale and general
psychological maladjustment, were significantly higher than
those of the control group. Bella’s score for aﬀective problems
was also significantly higher than controls.
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Table 1: Healthy control group (n = 15) compared to case study Bella at baseline and when recovered at one year follow-up.
Healthy controls Bella
Mean SD
Baseline
mean
t P zCC
One year
follow-up
mean
t P zCC
Awakening cortisol overall levels (mean in nmol/L) 36.37 (±10.70) 63.19∗ 2.43 0.02 2.51 45.10 0.80 0.22 0.82
Awakening cortisol dynamic (mean in nmol/L) 5.51 (±4.99) 8.80 0.65 0.26 0.67 5.27 −0.05 0.48 −0.05
Daytime cortisol overall levels (mean in nmol/L) 6.88 (±2.18) 11.30∗ 2.08 0.02 2.14 5.40 −0.66 0.26 −0.68
Daytime cortisol dynamic 0.69 (±1.32) 2.11 1.06 0.15 1.09 3.00 1.69 0.11 1.75
DHEA awakening levels (mean in nmol/L) 1.90 (±0.81) 3.64∗ 2.09 0.03 2.15 1.64 −0.31 0.38 −0.32
DHEA evening levels (mean in nmol/L) 0.53 (±0.30) 1.20∗ 2.07 0.03 2.17 0.78 0.10 0.46 −0.10
EDI-3 eating disorder risk 28.67 (±6.78) 40.00∗ 1.62 0.01 1.67 35.00 −1.16 0.13 1.20
EDI-3 drive for thinness 26.07 (±8.29) 38.00 1.39 0.09 1.44 32.00 0.69 0.50 0.72
EDI-3 bulimia 42.73 (±5.16) 41.00 −0.33 0.75 −0.34 41.00 −0.33 0.75 −0.34
EDI-3 body dissatisfaction 31.00 (±6.51) 48.00∗ 2.53 0.01 2.62 43.00 1.79 0.10 1.84
EDI-3 general psychological maladjustment 36.87 (±5.91) 49.00∗ 1.99 0.03 2.05 35.00 −0.31 0.38 −0.32
EDI-3 aﬀective problems 39.82 (±4.45) 50.00∗ 2.18 0.03 2.27 35.00 1.09 0.30 1.14
∗
P < 0.05 (indicates statistically significant diﬀerence to corresponding control value).
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Figure 1: Mean (±SEM) salivary cortisol concentrations (nmol/l) after awakening and over the daytime period for the healthy control group
(n = 15) and case study Bella at baseline and when recovered at one year follow-up.
2.5.2. Follow-Up. Bella was followed up one year after being
discharged from her programme at the service. She was man-
aging and maintaining her weight in the community and at
follow-up Bella’s weight was 58.5 kg with a BMI of 19 kg/m2.
After leaving inpatient treatment, Bella was transferred to
outpatient support in the form of a community practitioner
nurse whom she saw roughly every six weeks. At the time of
follow-up participation, Bella was at college getting ready to
take her A-level exams in a few months’ time and hoping to
go to university in the coming year. She was happy socially,
and had friends at college, including a boyfriend. She had just
also started a part-time job in a local retail establishment.
Bella completed the same protocol as before. Crawford
and Howell’s [30] approach was used once again to compare
Bella’s mean cortisol and DHEA composites for the two
samplings day to the corresponding values from the healthy
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Figure 2: Mean (±SEM) salivary DHEA concentrations (nmol/l)
after awakening and over the daytime period for the healthy control
group (n = 15) and case study Bella at baseline and when recovered
at one year follow-up.
control group. One year after being discharged from the
inpatient service when she was recovered, Bella’s overall levels
of cortisol after awakening were not significantly diﬀerent to
the control group and neither were her overall levels for the
rest of the day. Furthermore, the dynamic of Bella’s cortisol
profile did not diﬀer significantly to that of the controls for
either the CAR or the rest of the daytime period. Bella’s
cortisol profiles at follow-up can be seen in Figure 1 and
Table 1. Similarly for DHEA, Bella’s concentrations were all
comparable to the control group for both the 30 minute
post-awakening period and also in the evening. Bella’s DHEA
profiles at follow-up can be seen in Figure 2, and the
accompanying statistics can be seen in Table 1.
One year on, all of Bella’s EDI-3 scores had lowered
and were not significantly diﬀerent compared to the healthy
control group (see Table 1). Her general psychological mal-
adjustment and her aﬀective problems had improved to be
comparable to the healthy group, and notably, the EDI-3
qualitative classification for these two indices had lowered
from “typical clinical” during illness to “low clinical” at
follow-up.
3. Discussion
During illness, Bella’s measure of aﬀective problems was
outside of the normal range and her cortisol and DHEA
secretory profiles were significantly elevated across the
diurnal period. Despite hypersecretion of both hormones,
the dynamics of the diurnal profiles (e.g., for the CAR and
diurnal declines) remained comparable to controls, which
indicated hyperactivity of HPA axis drive overall, and not
CAR specific mechanisms (see [33] for a detailed discussion
of these physiological mechanisms). Bella’s clinical symp-
toms and overall levels of cortisol and DHEA were no longer
significantly diﬀerent to controls one year post-discharge
from treatment. At this point she was recovered and main-
taining life in the community. Bella’s EDI measure of her
aﬀective problems at follow-up had improved compared to
illness phase. This case study adds further support to existing
empirical work which illustrates that female adolescents
with AN have diﬃculties with emotional recognition and
regulation [6] and that intensive, aﬀect regulation focused
therapeutic milieu for the treatment of AN can have a
positive outcome.
The present case study is novel in that it illustrates
that the statistical techniques commonly used to illuminate
clinical outcomes in neuropsychology can be applied to
neuroendocrinology. Our approach has demonstrated that
research techniques can provide information for clinicians
that may potentially be used to monitor each individual’s
therapeutic progress. These techniques can be used in terms
of psychometric assessments such as the EDI, but also for
indices of HPA axis function. Although Bella was assessed
during her illness/treatment phase and one year post-
discharge, the statistical approach would be applicable at any
point during treatment and would enable both therapeutic
progress and vulnerability to be monitored [11].
In line with the present study, a recent cohort study of
210 females with AN reports that cortisol could be used as
an important prognostic predictor [34]. These authors found
increased levels of cortisol in AN patients who developed
critical states during the three month timescale of their study,
however cortisol was measured via plasma. It is noteworthy
that venipuncture can significantly enhance cortisol levels
in some participants, most probably reflecting a psycho-
logical stress response [35]. In another area of adolescent
psychopathology however, salivary HPA axis rhythms are
presently being utilised to monitor intervention eﬀorts for
adolescent depression (see [36]). Thus, salivary, as opposed
to plasma, indicators of HPA axis function could similarly
and feasibly be used to monitor prognosis and intervention
for adolescent AN. In line with the methodological approach
of the present case study, we propose that collecting saliva by
chewing on a cotton swab may be inappropriate and stressful
for individuals with AN; drooling passively into a plastic
tube, is considered the most non-intrusive and best-tolerated
method of saliva sampling in this population [37].
In conclusion, we encourage broader employment of
the neuroendocrine and the specialised statistical methods
outlined in this case study, as both approaches provide useful
information equally for researchers and clinicians working
in the field of adolescent AN. Furthermore, our case study
of Bella has illuminated the issue of assessing recovery in
AN, and supports the idea of clinicians incorporating both
measures of aﬀect and salivary HPA axis assessments, from
admission to post-treatment. Although our study is limited
to a single case study, our endeavour has been to provide
preliminary evidence that HPA axis activity can be routinely
measured via an easily accessible biological fluid as part
of a therapeutic treatment milieu for AN. Based on the
results of the current case study, we encourage future work
to investigate salivary cortisol and DHEA in larger group
designs to determine the extent to which these variables are
relevant for AN, especially with regard to measures of aﬀect.
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